Advertisement
Letter to the Editor| Volume 26, ISSUE 9, e54-e55, November 2015

Download started.

Ok

Depressive symptomatology in patients with metabolic syndrome: A cross-sectional study of stable coronary artery disease patients

Published:August 12, 2015DOI:https://doi.org/10.1016/j.ejim.2015.07.020
Depressive symptomatology in patients with metabolic syndrome: A cross-sectional study of stable coronary artery disease patients
Previous ArticleThe value of software that provides clinically relevant information on drug interactions
Next ArticleThe issue of dual infection with m.tuberculosis and non-mycobacterial pathogens
      The metabolic syndrome is a common disorder, which includes the presence of at least 3 out of 5 metabolic risk factors according to the National Cholesterol Education Program Adult Treatment Panel III [
      • Grundy S.M.
      • Cleeman J.I.
      • Daniels S.R.
      • Donato K.A.
      • Eckel R.H.
      • Franklin B.A.
      • et al.
      Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
      Circulation. 2005; 112: 2735-2752
      ]. It has been observed that metabolic syndrome is highly prevalent in patients with coronary artery disease (CAD) [
      • Chang J.J.
      • Chu C.M.
      • Wang P.C.
      • Lin Y.S.
      • Pan K.L.
      • Jang S.J.
      • et al.
      Differences in prevalence and severity of coronary artery disease by three metabolic syndrome definitions.
      Can. J. Cardiol. 2012; 28: 208-214
      ] and also depression is a common comorbidity in CAD with an increased risk of cardiovascular morbidity and mortality [
      • Parissis J.T.
      • Fountoulaki K.
      • Filippatos G.
      • Adamopoulos S.
      • Paraskevaidis I.
      • Kremastinos D.
      Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications.
      Int. J. Cardiol. 2007; 116: 153-160
      ,
      • Rallidis L.S.
      • Varounis C.
      • Sourides V.
      • Charalampopoulos A.
      • Kotakos C.
      • Liakos G.
      • et al.
      Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
      Curr. Med. Res. Opin. 2011; 27: 1407-1413
      ]. The aim of this study was to assess if depressive symptomatology is more prevalent in stable CAD patients with metabolic syndrome.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Grundy S.M.
        • Cleeman J.I.
        • Daniels S.R.
        • Donato K.A.
        • Eckel R.H.
        • Franklin B.A.
        • et al.
        Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
        Circulation. 2005; 112: 2735-2752
        View in Article
        • Chang J.J.
        • Chu C.M.
        • Wang P.C.
        • Lin Y.S.
        • Pan K.L.
        • Jang S.J.
        • et al.
        Differences in prevalence and severity of coronary artery disease by three metabolic syndrome definitions.
        Can. J. Cardiol. 2012; 28: 208-214
        View in Article
        • Parissis J.T.
        • Fountoulaki K.
        • Filippatos G.
        • Adamopoulos S.
        • Paraskevaidis I.
        • Kremastinos D.
        Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications.
        Int. J. Cardiol. 2007; 116: 153-160
        View in Article
        • Rallidis L.S.
        • Varounis C.
        • Sourides V.
        • Charalampopoulos A.
        • Kotakos C.
        • Liakos G.
        • et al.
        Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
        Curr. Med. Res. Opin. 2011; 27: 1407-1413
        View in Article
        • Zung W.
        A self-rating depression scale.
        Arch. Gen. Psychiatry. 1965; 12: 63-70
        View in Article
        • Vaccarino V.
        • McClure C.
        • Johnson B.D.
        • Sheps D.S.
        • Bittner V.
        • Rutledge T.
        • et al.
        Depression, the metabolic syndrome and cardiovascular risk.
        Psychosom. Med. 2008; 70: 40-48
        View in Article

      Article info

      Publication history

      Published online: August 12, 2015
      Accepted: July 30, 2015
      Received in revised form: July 28, 2015
      Received: July 25, 2015

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2015.07.020

      Copyright

      © 2015 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX